These results suggested that mice lacking PRDX6 were more prone to develop a severe form of liver dysfunction, such as NASH, highlighting the role of this antioxidant enzyme in the pathogenesis of metabolic liver disease in obese and diabetic conditions. The gene discussed is PRDX6; the disease is metabolic dysfunction-associated steatohepatitis.